National NESR Stock Today Drops 204 Key Support at 2419 20260517 HeartSciences HSCS Stock Slides 353 Support at 174 20260514 MiniMed Group MMED Surges 074 Nearing 1142 Resistance 20260518 Texas TXN Declines 169 Amid Market Weakness 20260518 Saratoga Investment Corp 850 Notes SAZ Edges Higher Amid Steady Trading Public Policy Holding Co Inc PPHC Q4 2025 Earnings Strong EPS Surprise Drives Stock Rally Southwest SWX Q1 2026 Underwhelms Revenue Pressure Hits Bottom Line TTEC Holdings TTEC Q1 2026 Miss Should Investors Be Worried US April Payrolls Beat Expectations But Report Flags Economic Concerns Chinas Big Three Airlines Face Steeper Challenges Amid High Jet Fuel Costs and Rail Competition Market Downturn Strategies Identifying Potential Defensive Stock Opportunities Seaport Research Upgrade Highlights Data Center Power Demand as Growth Catalyst for Texas Instruments SpaceXs Growth Prospects Tied to Starlink as IPO Prepares for Nasdaq Listing Cornwalls Nansledan Development A Retail Blueprint or a Threat to Newquays High Street LYB Q1 2026 Earnings EPS Smashes Estimates Despite Stock Decline MTA Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Broader Sentiment ABT Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Lower LUCY Q1 2026 Earnings EPS Surprises with a 2282 Beat Despite Missing Revenue Details SLSR Q1 2026 Earnings Narrowing Losses Despite Market Headwinds Legal Turbulence Erupts States Challenge Prediction Markets as Regulators Weigh In IonQ Q1 2026 Earnings EPS Surprise Beats Estimates as Stock Jumps 12 My Size Inc MYSZ Q4 2025 Earnings EPS Misses Estimates as Shares Decline OpenAI Reportedly Plans Confidential IPO Filing by May 22 Potential Valuation Up to 1 Trillion NXPL Q1 2026 Earnings Loss Per Share Narrows as Stock Gains on Strategic Progress CARE Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction FOSL Fossil Group posts massive Q4 2025 EPS miss 123 revenue decline shares slip 221 Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Brief CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline